Capital International Investors
CLB icon

Capital International Investors’s Core Laboratories CLB Stock Holding History

Capital International Investors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-280,574
Closed -$14.7M – 408
2019
Q2 		$14.7M Sell
280,574
-75,818
-21% -$4.45M 0.01% 350
2019
Q1 		$24.6M Sell
356,392
-65,246
-15% -$4.37M 0.01% 317
2018
Q4 		$25.2M Sell
421,638
-325
-0.1% -$28K 0.01% 294
2018
Q3 		$48.9M Buy
421,963
+2,486
+0.6% +$280K 0.02% 271
2018
Q2 		$52.9M Buy
419,477
+2,026
+0.5% +$247K 0.06% 178
2018
Q1 		$45.2M Buy
417,451
+1,740
+0.4% +$193K 0.05% 191
2017
Q4 		$45.5M Buy
415,711
+1,729
+0.4% +$173K 0.05% 190
2017
Q3 		$40.9M Buy
413,982
+1,271
+0.3% +$123K 0.05% 206
2017
Q2 		$41.8M Buy
412,711
+1,095
+0.3% +$118K 0.06% 206
2017
Q1 		$47.5M Buy
411,616
+1,289
+0.3% +$150K 0.06% 198
2016
Q4 		$49.3M Buy
+410,327
New +$45.4M 0.07% 188

Other funds holding CLB

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors's CLB Position: Q3 2019 in Review

Capital International Investors sold out of Core Laboratories (CLB) in Q3 2019, closing a stake of 280,574 shares — an estimated $14.7M sold.

Capital International Investors first reported a position in CLB in Q4 2016 and held it in 11 quarters. The position peaked at $52.9M in Q2 2018. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

  • Capital International Investors reported no remaining Core Laboratories position as of Q3 2019 after selling out during the quarter.
  • Capital International Investors sold 280,574 Core Laboratories shares in Q3 2019, an estimated $14.7M.
  • Capital International Investors first reported a position in Core Laboratories in Q4 2016 and held it in 11 quarters.
  • Capital International Investors's Core Laboratories position peaked at $52.9M in Q2 2018.
  • 274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on Capital International Investors's 13F filing for Q3 2019, filed 14 Nov 2019.